Business Description
Vivesto AB
NAICS : 325412
ISIN : SE0000722365
Compare
Compare
Traded in other countries / regions
VIVE.SwedenOMAX.GermanyOASMY.USA0N4A.UK IPO Date
2005-12-30Description
Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.92 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -62.5 | |||||
| 3-Year EPS without NRI Growth Rate | -106.9 | |||||
| 3-Year FCF Growth Rate | -37.2 | |||||
| 3-Year Book Growth Rate | -41.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 23.85 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.72 | |||||
| 9-Day RSI | 40.9 | |||||
| 14-Day RSI | 44.21 | |||||
| 6-1 Month Momentum % | -2.55 | |||||
| 12-1 Month Momentum % | -12.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.97 | |||||
| Quick Ratio | 2.97 | |||||
| Cash Ratio | 2.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.3 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -46.87 | |||||
| ROA % | -42.74 | |||||
| ROIC % | -61.89 | |||||
| 3-Year ROIIC % | 28.79 | |||||
| ROC (Joel Greenblatt) % | -858.16 | |||||
| ROCE % | -46.79 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.84 | |||||
| Price-to-Tangible-Book | 4.42 | |||||
| EV-to-EBIT | -0.69 | |||||
| EV-to-Forward-EBIT | -0.43 | |||||
| EV-to-EBITDA | -1.53 | |||||
| EV-to-Forward-EBITDA | -0.57 | |||||
| EV-to-Forward-Revenue | 7.11 | |||||
| EV-to-FCF | -1.38 | |||||
| Price-to-Net-Current-Asset-Value | 4.42 | |||||
| Price-to-Net-Cash | 5.3 | |||||
| Earnings Yield (Greenblatt) % | -144.01 | |||||
| FCF Yield % | -32.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vivesto AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.18 | ||
| Beta | 0.6 | ||
| Volatility % | 36.48 | ||
| 14-Day RSI | 44.21 | ||
| 14-Day ATR (kr) | 0.014214 | ||
| 20-Day SMA (kr) | 0.275 | ||
| 12-1 Month Momentum % | -12.75 | ||
| 52-Week Range (kr) | 0.2165 - 0.55 | ||
| Shares Outstanding (Mil) | 538.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vivesto AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vivesto AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vivesto AB Frequently Asked Questions
What is Vivesto AB(OSTO:VIVE)'s stock price today?
The current price of OSTO:VIVE is kr0.27. The 52 week high of OSTO:VIVE is kr0.55 and 52 week low is kr0.22.
When is next earnings date of Vivesto AB(OSTO:VIVE)?
The next earnings date of Vivesto AB(OSTO:VIVE) is 2025-02-20.
Does Vivesto AB(OSTO:VIVE) pay dividends? If so, how much?
Vivesto AB(OSTO:VIVE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers